Literature DB >> 20179353

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Karine Labadie1, Thibaut Larcher, Christophe Joubert, Abdelkrim Mannioui, Benoit Delache, Patricia Brochard, Lydie Guigand, Laurence Dubreil, Pierre Lebon, Bernard Verrier, Xavier de Lamballerie, Andreas Suhrbier, Yan Cherel, Roger Le Grand, Pierre Roques.   

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that induces in humans a disease characterized by fever, rash, and pain in muscles and joints. The recent emergence or reemergence of CHIKV in the Indian Ocean Islands and India has stressed the need to better understand the pathogenesis of this disease. Previous CHIKV disease models have used young or immunodeficient mice, but these do not recapitulate human disease patterns and are unsuitable for testing immune-based therapies. Herein, we describe what we believe to be a new model for CHIKV infection in adult, immunocompetent cynomolgus macaques. CHIKV infection in these animals recapitulated the viral, clinical, and pathological features observed in human disease. In the macaques, long-term CHIKV infection was observed in joints, muscles, lymphoid organs, and liver, which could explain the long-lasting CHIKV disease symptoms observed in humans. In addition, the study identified macrophages as the main cellular reservoirs during the late stages of CHIKV infection in vivo. This model of CHIKV physiopathology should allow the development of new therapeutic and/or prophylactic strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20179353      PMCID: PMC2827953          DOI: 10.1172/JCI40104

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  71 in total

1.  Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein.

Authors:  Anne-Claire Bréhin; Laetitia Rubrecht; Martha Erika Navarro-Sanchez; Valérie Maréchal; Marie-Pascale Frenkiel; Priscilla Lapalud; Daniel Laune; Amadou Alpha Sall; Philippe Desprès
Journal:  Virology       Date:  2007-10-18       Impact factor: 3.616

Review 2.  Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus.

Authors:  Ann M Powers; Christopher H Logue
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

3.  Clinical burden of chikungunya virus infection.

Authors:  Benjamin Queyriaux; Fabrice Simon; Marc Grandadam; Rémy Michel; Hugues Tolou; Jean-Paul Boutin
Journal:  Lancet Infect Dis       Date:  2008-01       Impact factor: 25.071

4.  A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006.

Authors:  Philippe Renault; Jean-Louis Solet; Daouda Sissoko; Elsa Balleydier; Sophie Larrieu; Laurent Filleul; Christian Lassalle; Julien Thiria; Emmanuelle Rachou; Henriette de Valk; Daniele Ilef; Martine Ledrans; Isabelle Quatresous; Philippe Quenel; Vincent Pierre
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

Review 5.  Tumor necrosis factor as a therapeutic target of rheumatologic disease.

Authors:  Christoph Ackermann; Arthur Kavanaugh
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

6.  Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus.

Authors:  Marie Vazeille; Sara Moutailler; Daniel Coudrier; Claudine Rousseaux; Huot Khun; Michel Huerre; Julien Thiria; Jean-Sébastien Dehecq; Didier Fontenille; Isabelle Schuffenecker; Philippe Despres; Anna-Bella Failloux
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

7.  Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.

Authors:  Patrick Gérardin; Georges Barau; Alain Michault; Marc Bintner; Hanitra Randrianaivo; Ghassan Choker; Yann Lenglet; Yasmina Touret; Anne Bouveret; Philippe Grivard; Karin Le Roux; Séverine Blanc; Isabelle Schuffenecker; Thérèse Couderc; Fernando Arenzana-Seisdedos; Marc Lecuit; Pierre-Yves Robillard
Journal:  PLoS Med       Date:  2008-03-18       Impact factor: 11.069

8.  Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006.

Authors:  Marcus Panning; Klaus Grywna; Marjan van Esbroeck; Petra Emmerich; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

9.  Characterization of reemerging chikungunya virus.

Authors:  Marion Sourisseau; Clémentine Schilte; Nicoletta Casartelli; Céline Trouillet; Florence Guivel-Benhassine; Dominika Rudnicka; Nathalie Sol-Foulon; Karin Le Roux; Marie-Christine Prevost; Hafida Fsihi; Marie-Pascale Frenkiel; Fabien Blanchet; Philippe V Afonso; Pierre-Emmanuel Ceccaldi; Simona Ozden; Antoine Gessain; Isabelle Schuffenecker; Bruno Verhasselt; Alessia Zamborlini; Ali Saïb; Felix A Rey; Fernando Arenzana-Seisdedos; Philippe Desprès; Alain Michault; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2007-06       Impact factor: 6.823

10.  A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Authors:  Thérèse Couderc; Fabrice Chrétien; Clémentine Schilte; Olivier Disson; Madly Brigitte; Florence Guivel-Benhassine; Yasmina Touret; Georges Barau; Nadège Cayet; Isabelle Schuffenecker; Philippe Desprès; Fernando Arenzana-Seisdedos; Alain Michault; Matthew L Albert; Marc Lecuit
Journal:  PLoS Pathog       Date:  2008-02-08       Impact factor: 6.823

View more
  218 in total

1.  A nonhuman primate model of chikungunya disease.

Authors:  Stephen Higgs; Sarah A Ziegler
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  The growth of arthralgic Ross River virus is restricted in human monocytic cells.

Authors:  Pascale Krejbich-Trotot; Essia Belarbi; Miora Ralambondrainy; Chaker El-Kalamouni; Wildriss Viranaicken; Pierre Roques; Philippe Desprès; Gilles Gadea
Journal:  Virus Res       Date:  2016-09-13       Impact factor: 3.303

3.  Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.

Authors:  Chad J Roy; A Paige Adams; Eryu Wang; Kenneth Plante; Rodion Gorchakov; Robert L Seymour; Heather Vinet-Oliphant; Scott C Weaver
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

4.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  Chikungunya fever: focus on peripheral markers of pathogenesis.

Authors:  Pierre Roques; Gabriel Gras
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

6.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Structural basis for complementary and alternative medicine: Phytochemical interaction with non-structural protein 2 protease-a reverse engineering strategy.

Authors:  G Koushik Kumar; G Prasanna; T Marimuthu; N T Saraswathi
Journal:  Chin J Integr Med       Date:  2014-12-09       Impact factor: 1.978

8.  The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika and chikungunya is immunogenic in non-human primates.

Authors:  Natalie A Prow; Liang Liu; Mary K McCarthy; Kevin Walters; Raj Kalkeri; Jillian Geiger; Fusataka Koide; Tamara H Cooper; Preethi Eldi; Eri Nakayama; Kerrilyn R Diener; Paul M Howley; John D Hayball; Thomas E Morrison; Andreas Suhrbier
Journal:  NPJ Vaccines       Date:  2020-06-02       Impact factor: 7.344

9.  Association of ABO blood groups with Chikungunya virus.

Authors:  Naresh C V M Kumar; Mahathi Nadimpalli; Vishnu R Vardhan; Sai D V R Gopal
Journal:  Virol J       Date:  2010-06-25       Impact factor: 4.099

10.  Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.

Authors:  Angela Chow; Zhisheng Her; Edward K S Ong; Jin-miao Chen; Frederico Dimatatac; Dyan J C Kwek; Timothy Barkham; Henry Yang; Laurent Rénia; Yee-Sin Leo; Lisa F P Ng
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.